Madam Speaker, I am pleased to present another five petitions today regarding chronic cerebrospinal venous insufficiency.
MS patients are frustrated with being told to wait for Canadian replication of correlation studies. Since the fall, I have been presenting international studies that show that 80% to 97% of MS patients have one or more venous abnormalities depending on the diagnostic or treatment method used. New data from the conference in Poland earlier this month show that in Bulgaria, Jordan, Poland and the United Kingdom upwards of 93% of MS patients have evidence of CCSVI. New data from the conference in Italy last week showed 700 cases analyzed from multiple international centres with 86% of MS patients having CCSVI.
Therefore, the petitioners are calling for clinical trials with diagnosis, treatment and follow-up here in Canada.